ArticleMolecular cancer therapeutics2013

The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.

Yun Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.